CELLULARLINE risk profile
37 Normal where most of the sector sits
Measured 1 September 2026 from CELL.MI's filed statements. Recomputed nightly.
37 (Normal), driven by Operating pressure at 45, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 35 | Normal | Stable | One-year price volatility — 21.3% |
| Operating pressure | 45 | Elevated | Worsening | Costs outgrowing revenue — +2.4 percentage points |
| Cash conversion | 32 | Normal | Worsening | Capital spending against operating cash — 0.29x |
| Leverage and coverage | 15 | Contained | Easing | Current ratio — 2.20x |
| Competitive position | 43 | Elevated | Stable | Operating-margin gap against peers — +0.3 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.